{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:48:57Z","timestamp":1782449337312,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05387-1","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T06:35:13Z","timestamp":1780814113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Wubing","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"issue":"1","key":"5387_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58. https:\/\/doi.org\/10.1038\/s41572-023-00468-9.","journal-title":"Nat Rev Dis Primers"},{"key":"5387_CR2","doi-asserted-by":"publisher","first-page":"1572034","DOI":"10.3389\/fimmu.2025.1572034","volume":"16","author":"H Yan","year":"2025","unstructured":"Yan H, Ji X, Li B. Advancing personalized, predictive, and preventive medicine in bladder cancer: a multiomics and machine learning approach for novel prognostic modeling, immune profiling, and therapeutic target discovery. Front Immunol. 2025;16:1572034. https:\/\/doi.org\/10.3389\/fimmu.2025.1572034.","journal-title":"Front Immunol"},{"issue":"27","key":"5387_CR3","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1200\/JCO.23.00725","volume":"41","author":"M Swinton","year":"2023","unstructured":"Swinton M, Mariam NBG, Tan JL, et al. Bladder-sparing treatment with radical dose radiotherapy is an effective alternative to radical cystectomy in patients with clinically node-positive nonmetastatic bladder cancer. J Clin Oncol. 2023;41(27):4406\u201315. https:\/\/doi.org\/10.1200\/JCO.23.00725.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5387_CR4","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41467-023-37568-9","volume":"14","author":"AG Robertson","year":"2023","unstructured":"Robertson AG, Meghani K, Cooley LF, et al. Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer. Nat Commun. 2023;14(1):2126. https:\/\/doi.org\/10.1038\/s41467-023-37568-9.","journal-title":"Nat Commun"},{"key":"5387_CR5","doi-asserted-by":"publisher","first-page":"105152","DOI":"10.1016\/j.ebiom.2024.105152","volume":"104","author":"L Liu","year":"2024","unstructured":"Liu L, Xu L, Wu D, et al. Impact of tumor stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer. EBioMedicine. 2024;104:105152. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105152.","journal-title":"EBioMedicine"},{"issue":"6","key":"5387_CR6","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1002\/mco2.455","volume":"4","author":"M Peng","year":"2023","unstructured":"Peng M, Chu X, Peng Y, et al. Targeted therapies in bladder cancer: signaling pathways, applications, and challenges. MedComm. 2023;4(6):e455. https:\/\/doi.org\/10.1002\/mco2.455. Published 2023 Dec 15.","journal-title":"MedComm"},{"issue":"6","key":"5387_CR7","doi-asserted-by":"publisher","first-page":"114369","DOI":"10.1016\/j.celrep.2024.114369","volume":"43","author":"S Garbo","year":"2024","unstructured":"Garbo S, D\u2019Andrea D, et al. m6A modification inhibits miRNAs\u2019 intracellular function, favoring their extracellular export for intercellular communication. Cell Rep. 2024;43(6):114369. https:\/\/doi.org\/10.1016\/j.celrep.2024.114369.","journal-title":"Cell Rep"},{"issue":"2","key":"5387_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1152\/physrev.00043.2019","volume":"101","author":"JC Chatham","year":"2021","unstructured":"Chatham JC, Zhang J, Wende AR. Role of O-linked N-acetylglucosamine protein modification in cellular (patho)physiology. Physiol Rev. 2021;101(2):427\u201393. https:\/\/doi.org\/10.1152\/physrev.00043.2019.","journal-title":"Physiol Rev"},{"key":"5387_CR9","doi-asserted-by":"publisher","unstructured":"Lu J, Li N, Li G, Lin J, et al. N-glycosylation of SnRK2s affects NADPH maintenance in peroxisomes during prolonged ABA signalling. Nat Commun. 2024;15(1):6630. https:\/\/doi.org\/10.1038\/s41467-024-50720-3.","DOI":"10.1038\/s41467-024-50720-3"},{"issue":"7","key":"5387_CR10","doi-asserted-by":"publisher","first-page":"ar87","DOI":"10.1091\/mbc.E24-12-0556","volume":"36","author":"FT Sumya","year":"2025","unstructured":"Sumya FT, Aragon-Ramirez WS, Lupashin VV. Deep proteomic profiling of the intra-golgi trafficking intermediates. Mol Biol Cell. 2025;36(7):ar87. https:\/\/doi.org\/10.1091\/mbc.E24-12-0556.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"5387_CR11","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1021\/acs.chemrev.0c00884","volume":"121","author":"J Ma","year":"2021","unstructured":"Ma J, Wu C, Hart GW. Analytical and biochemical perspectives of protein O-GlcNAcylation. Chem Rev. 2021;121(3):1513\u201381. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00884.","journal-title":"Chem Rev"},{"issue":"43","key":"5387_CR12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303703120","volume":"120","author":"W Yang","year":"2023","unstructured":"Yang W, Tian E, Chernish A, et al. Quantitative mapping of the in vivo O-GalNAc glycoproteome in mouse tissues identifies GalNAc-T2 O-glycosites in metabolic disorder. Proc Natl Acad Sci U S A. 2023;120(43):e2303703120. https:\/\/doi.org\/10.1073\/pnas.2303703120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5387_CR13","doi-asserted-by":"publisher","unstructured":"Xu X, Peng Q, Jiang X, Peng M, et al. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Exp Mol Med. 2023;55(7):1357\u201370. https:\/\/doi.org\/10.1038\/s12276-023-01020-1.","DOI":"10.1038\/s12276-023-01020-1"},{"issue":"1","key":"5387_CR14","doi-asserted-by":"publisher","first-page":"9043012","DOI":"10.1155\/2020\/9043012","volume":"2020","author":"L Hui","year":"2020","unstructured":"Hui L. Two time point analysis of the change in risk and aging factors for major cancers: a 10-year longitudinal study in China. BioMed Research International. 2020;2020:9043012. https:\/\/doi.org\/10.1155\/2020\/9043012.","journal-title":"BioMed Research International"},{"key":"5387_CR15","doi-asserted-by":"publisher","unstructured":"Kang N, Son S, Min S, Kang H, et al. Stimuli-responsive ferroptosis for cancer therapy. Chem Soc Rev. 2023;52(12):3955\u201372. https:\/\/doi.org\/10.1039\/d3cs00001j.","DOI":"10.1039\/d3cs00001j"},{"issue":"14","key":"5387_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412985","volume":"12","author":"X Wan","year":"2025","unstructured":"Wan X, Gong R, et al. Identification of a novel substrate for eEF2K and the AURKA-SOX8 as the related pathway in TNBC. Advanced Science. 2025;12(14):e2412985. https:\/\/doi.org\/10.1002\/advs.202412985.","journal-title":"Advanced Science"},{"issue":"1","key":"5387_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","volume":"9","author":"M He","year":"2024","unstructured":"He M, Zhou X. Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Ther. 2024;9(1):194. https:\/\/doi.org\/10.1038\/s41392-024-01886-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"5387_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012391","volume":"13","author":"SS Pinho","year":"2025","unstructured":"Pinho SS, Macauley MS, et al. Tumor glyco-immunology, glyco-immune checkpoints and immunotherapy. J Immunother Cancer. 2025;13(6):e012391. https:\/\/doi.org\/10.1136\/jitc-2025-012391.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"5387_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tips.2025.07.013","volume":"46","author":"Q Zhu","year":"2025","unstructured":"Zhu Q, Chen X, et al. Targeting glycosylation to enhance tumor immunotherapy. Trends Pharmacol Sci. 2025;46(9):863\u201376. https:\/\/doi.org\/10.1016\/j.tips.2025.07.013.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"5387_CR20","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.apsb.2023.10.014","volume":"14","author":"Y Lin","year":"2024","unstructured":"Lin Y, Lubman DM. The role of N-glycosylation in cancer. Acta Pharm Sin B. 2024;14(3):1098\u2013110. https:\/\/doi.org\/10.1016\/j.apsb.2023.10.014.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"5387_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12935-025-04133-x","volume":"26","author":"H Dai","year":"2026","unstructured":"Dai H, Zhang X, Yin L, et al. Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma. Cancer Cell Int. 2026;26(1):15. https:\/\/doi.org\/10.1186\/s12935-025-04133-x.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"5387_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13062-025-00650-x","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai H, Yu Z, Zhao Y, et al. Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer. Biol Direct. 2025;20(1):56. https:\/\/doi.org\/10.1186\/s13062-025-00650-x.","journal-title":"Biol Direct"},{"issue":"1","key":"5387_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41065-025-00409-4","volume":"162","author":"H Dai","year":"2025","unstructured":"Dai H, Zhang X, Zhao Y, et al. ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment. Hereditas. 2025;162(1):42. https:\/\/doi.org\/10.1186\/s41065-025-00409-4.","journal-title":"Hereditas"},{"issue":"D1","key":"5387_CR24","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 2025;53(D1):D672-7. https:\/\/doi.org\/10.1093\/nar\/gkae909.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5387_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13073-025-01543-4","volume":"17","author":"K Lavrichenko","year":"2025","unstructured":"Lavrichenko K, Engdal ES, Marvig RL, et al. Recommendations for bioinformatics in clinical practice. Genome Med. 2025;17(1):124. https:\/\/doi.org\/10.1186\/s13073-025-01543-4. Published 2025 Oct 17.","journal-title":"Genome Med"},{"issue":"1","key":"5387_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13008-025-00172-y","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai H, Wang X, Wu Q, et al. Integrating genetic crosstalk between atherosclerosis and lung adenocarcinoma to advance precision diagnosis and treatment. Cell Div. 2025;20(1):27. https:\/\/doi.org\/10.1186\/s13008-025-00172-y.","journal-title":"Cell Div"},{"issue":"1","key":"5387_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12894-025-01914-4","volume":"25","author":"H Dai","year":"2025","unstructured":"Dai H, Zhao K, Zhao Y, et al. Machine learning model in multi-omics perspective demystifies the prognostic significance of crotonylation heterogeneity in clear cell renal cell carcinoma. BMC Urol. 2025;25(1):229. https:\/\/doi.org\/10.1186\/s12894-025-01914-4.","journal-title":"BMC Urol"},{"issue":"5","key":"5387_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.eururo.2025.04.008","volume":"88","author":"CE Chu","year":"2025","unstructured":"Chu CE, Chen Z, Whiting K, et al. Clinical outcomes, genomic heterogeneity, and therapeutic considerations across histologic subtypes of urothelial carcinoma. Eur Urol. 2025;88(5):472\u201381. https:\/\/doi.org\/10.1016\/j.eururo.2025.04.008.","journal-title":"Eur Urol"},{"issue":"3","key":"5387_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.145","volume":"3","author":"Y He","year":"2020","unstructured":"He Y, Su Y, Zeng J, et al. Cancer-specific survival after diagnosis in men versus women: a pan-cancer analysis. MedComm (2020). 2020;3(3):e145. https:\/\/doi.org\/10.1002\/mco2.145.","journal-title":"MedComm (2020)"},{"issue":"5","key":"5387_CR30","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1097\/JS9.0000000000001194","volume":"110","author":"Z Wei","year":"2024","unstructured":"Wei Z, Xv Y. A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study. Int J Surg. 2024;110(5):2922\u201332. https:\/\/doi.org\/10.1097\/JS9.0000000000001194.","journal-title":"Int J Surg"},{"issue":"1","key":"5387_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-021-01932-8","volume":"40","author":"X Sun","year":"2021","unstructured":"Sun X, He Z, Guo L, et al. ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-\u03b2 receptor II in breast cancer. J Exp Clin Cancer Res. 2021;40(1):149. https:\/\/doi.org\/10.1186\/s13046-021-01932-8.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5387_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.annonc.2023.10.125","volume":"35","author":"A Prelaj","year":"2024","unstructured":"Prelaj A, Miskovic V, et al. Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review. Ann Oncol. 2024;35(1):29\u201365. https:\/\/doi.org\/10.1016\/j.annonc.2023.10.125.","journal-title":"Ann Oncol"},{"issue":"5","key":"5387_CR33","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.7150\/ijbs.101585","volume":"21","author":"Z Wang","year":"2025","unstructured":"Wang Z, Jin Y, et al. Targeting ALG3\/FOXD1\/BNIP3 axis prevents mitophagy and gemcitabine resistance of nasopharyngeal carcinoma. Int J Biol Sci. 2025;21(5):1894\u2013913. https:\/\/doi.org\/10.7150\/ijbs.101585. Published 2025 Feb 10.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"5387_CR34","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1105\/tpc.114.123588","volume":"26","author":"XL Chen","year":"2014","unstructured":"Chen XL, Shi T. N-glycosylation of effector proteins by an \u03b1-1,3-mannosyltransferase is required for the rice blast fungus to evade host innate immunity. Plant Cell. 2014;26(3):1360\u201376. https:\/\/doi.org\/10.1105\/tpc.114.123588.","journal-title":"Plant Cell"},{"key":"5387_CR35","doi-asserted-by":"publisher","first-page":"112875","DOI":"10.1016\/j.intimp.2024.112875","volume":"140","author":"B Luo","year":"2024","unstructured":"Luo B, Liu X, Zhang Q, et al. ALG3 predicts poor prognosis and increases resistance to anti-PD-1 therapy through modulating PD-L1 N-link glycosylation in TNBC. Int Immunopharmacol. 2024;140:112875. https:\/\/doi.org\/10.1016\/j.intimp.2024.112875.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"5387_CR36","doi-asserted-by":"publisher","first-page":"110582","DOI":"10.1016\/j.jbc.2025.110582","volume":"301","author":"AJ Navarro-Traxler","year":"2025","unstructured":"Navarro-Traxler AJ, Ghisolfi L, Lien EC, Toker A. The glycosyltransferase ALG3 is an AKT substrate that regulates protein N-glycosylation. J Biol Chem. 2025;301(9):110582. https:\/\/doi.org\/10.1016\/j.jbc.2025.110582.","journal-title":"J Biol Chem"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05387-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:23:23Z","timestamp":1782447803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05387-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5387"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05387-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of The First Affiliated Hospital of Chongqing Medical University (Approval No. 2025\u2009\u2212\u20090918). This study was performed in accordance with the principles stated in the Declaration of Helsinki (https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki\/). Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients provided informed consent for the publication of their anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"939"}}